Elite Pharmaceuticals, Inc. ELTP
0.24 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.231 Day range 0.249
0.21 52-week range 0.69
- YTD
- -51.02%
- 1 year
- -61.90%
News
newsfilecorp.com Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2027 Financial Results on November 13, 2026 Financials for Second Quarter of Fiscal Year 2027 Ended September 30, 2026 will be released on Thursday, November 12, 2026 Northvale, New Jersey--(Newsfile Corp. - November 10, 2026) - Elite…
newsfilecorp.com Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D. Northvale, New Jersey--(Newsfile Corp. - November 3, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic…
zacks.com Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? ELTP and AYTU have different CNS portfolios, growth drivers and valuations, but which pharmaceutical stock looks better positioned? Let's dive in.
zacks.com ELTP Downgraded to Neutral on Pricing Pressure & Limited Visibility Elite Pharmaceuticals' downgrade to Neutral cites pricing pressure, weaker revenue and margins, and limited visibility into new-product contributions.
zacks.com ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy? Elite Pharmaceuticals and Journey Medical follow different growth paths, but which looks more compelling now? Let's dive in.
zacks.com Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y ELTP's first-quarter fiscal 2027 revenues decline as generic competition and lower pricing offset higher volumes, while pipeline development remains a growth focus.
seekingalpha.com Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript
marketbeat.com Elite Pharmaceuticals Q1 Earnings Call Highlights Elite Pharmaceuticals OTCMKTS: ELTP reported first-quarter fiscal 2027 revenue of $32.4 million and operating profit of $7.5 million, with Chief Financial Officer Carter Ward describing both measures…
newsfilecorp.com Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information Conference Call Scheduled for Friday, August 14, 2026 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - August 13, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"),…
newsfilecorp.com Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026 Financials for First Quarter of Fiscal Year 2027 Ended June 30, 2026 will be released on Thursday, August 13, 2026 Northvale, New Jersey--(Newsfile Corp. - August 10, 2026) - Elite Pharmaceuticals,…
newsfilecorp.com Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,…
defenseworld.net Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below Two Hundred Day Moving Average – Time to Sell? Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report)'s stock price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.38 and traded…
zacks.com Possible Generic Drug Tariffs and 2 Microcaps Generic drug tariffs could impact ELTP and CPIX.
zacks.com ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now? Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.
zacks.com Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.
seekingalpha.com Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript
newsfilecorp.com Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information Conference Call Scheduled for Tuesday, June 30 at 11:30 AM EDT Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a…
newsfilecorp.com Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026 Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP)…
newsfilecorp.com Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development,…
newsfilecorp.com Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product Northvale, New Jersey--(Newsfile Corp. - June 1, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development,…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday